Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Breast Revision: later-stage trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Breast Revision: 2 US clinical trials tracked, none currently recruiting.

Breast Revision is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Mentor Worldwide, running 2 of these trials.

Enrollment posture brief

Registry condition breast-revision

OPEN 0 | RECR 0% | LATE 2 | EARLY 0 | RANK #7188 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Breast Revision (this)0%
Open-enrollment share among volume-matched conditions near Breast Revision

Breast Revision has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Breast Revision on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Breast Revision is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 32

Phase Distribution

PhaseTrial count
Phase 3 2

Top Sponsors

Mentor Worldwide 2 trials

Named interventions

Most-linked intervention names on Breast Revision records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mentor Siltex® Contour Profile Gel Mammary Prosthesis Device
1 trials
The Contour Profile Gel (CPG) breast implants Device
1 trials

US sites by state

Facility locations filed on Breast Revision trials. A trial with sites in several states counts in each.

California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Breast Revision page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Breast Revision trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Mentor Worldwide sponsors the most Breast Revision trials on record, review their full trial history before evaluating a specific study. See Mentor Worldwide's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Revision condition card totals 2 registered trials; most-linked intervention Mentor Siltex® Contour Profile Gel Mammary Prosthesis; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.